Next Article in Journal
Mitochondrial Modulators: The Defender
Previous Article in Journal
Systemic Metabolomic Profiles in Adult Patients with Bacterial Sepsis: Characterization of Patient Heterogeneity at the Time of Diagnosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 13
Issue 2
10.3390/biom13020225
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Biomolecules 2021, 11(4), 582.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582

by
Fei Wang
1,2,* and
Gabriele Multhoff
1,3
1
Radiation-Immuno Oncology Group, TranslaTUM—Central Institute for Translational Cancer Research, Klinikum rechts der Isar, TU München, Einsteinstr. 25, 81675 Munich, Germany
2
Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China
3
Department of Radiation Oncology, Klinikum rechts der Isar, TU München, 81675 Munich, Germany
*
Author to whom correspondence should be addressed.
Biomolecules 2023, 13(2), 225; https://doi.org/10.3390/biom13020225
Submission received: 16 January 2023 / Accepted: 17 January 2023 / Published: 24 January 2023
Versions Notes
There was a misplaced reference in the original article in the first paragraph of Section 6 “Clinical Trials with CBD” [1]. By misplacing reference 138 in the original article, an inaccurate interpretation of the study was made.
The amendment is listed below, to which in addition, a sentence has been removed in order to maintain the paragraph’s readability:
“Due to its non-psychoactive characteristics, CBD is superior to other cannabinoids in clinical applications. A double-blind, placebo-controlled, randomized clinical phase I trial has been started to prove its safety and capability to relieve tumor-related adverse effects at a CBD concentration of 100 mg/mL, within a dose range of 50 mg to 600 mg per day, in 2 weeks [138].”
The authors apologize for any inconvenience caused and state that the conclusions of the original article have been unaffected. The original publication has been updated.

Reference

  1. Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wang, F.; Multhoff, G. Correction: Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582. Biomolecules 2023, 13, 225. https://doi.org/10.3390/biom13020225

AMA Style

Wang F, Multhoff G. Correction: Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582. Biomolecules. 2023; 13(2):225. https://doi.org/10.3390/biom13020225

Chicago/Turabian Style

Wang, Fei, and Gabriele Multhoff. 2023. "Correction: Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582" Biomolecules 13, no. 2: 225. https://doi.org/10.3390/biom13020225

APA Style

Wang, F., & Multhoff, G. (2023). Correction: Wang, F.; Multhoff, G. Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies. Biomolecules 2021, 11, 582. Biomolecules, 13(2), 225. https://doi.org/10.3390/biom13020225

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop